Cargando…

Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study

BACKGROUND: Antimicrobial drug resistance is one of the top ten threats to global health according to the World Health Organization. Urinary tract infections (UTIs) are among the most common bacterial infections and main reason for antibiotic prescription. The incidence of UTIs appears to be high am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abongomera, George, Koller, Maurice, Musaazi, Joseph, Lamorde, Mohammed, Kaelin, Marisa, Tasimwa, Hannington B., Eberhard, Nadia, Hongler, Jan, Haller, Sabine, Kambugu, Andrew, Castelnuovo, Barbara, Fehr, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609806/ https://www.ncbi.nlm.nih.gov/pubmed/34814849 http://dx.doi.org/10.1186/s12879-021-06865-3

Ejemplares similares

Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda
por: Sekaggya Wiltshire, Christine, et al.
Publicado: (2014)

Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study
por: Sekaggya-Wiltshire, Christine, et al.
Publicado: (2017)

‘Out of sight, out of mind?’ A follow-up on HIV-infected patients with drug-resistant pulmonary tuberculosis in Uganda: A case series
por: Notarfrancesco, Marco, et al.
Publicado: (2021)

Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study
por: Buzibye, Allan, et al.
Publicado: (2019)

Potential impact of task-shifting on costs of antiretroviral therapy and physician supply in Uganda
por: Babigumira, Joseph B, et al.
Publicado: (2009)

Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2015)

Prevalence of Escherichia Coli and Its Antimicrobial Susceptibility Profiles among Patients with UTI at Mulago Hospital, Kampala, Uganda
por: Odongo, Isaac, et al.
Publicado: (2020)

Incidence rate of sexually transmitted infections among HIV infected patients on long-term ART in an urban and a rural clinic in Uganda
por: Okoboi, Stephen, et al.
Publicado: (2019)

Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis
por: Kwizera, Richard, et al.
Publicado: (2017)

Asymptomatic Bacteriuria Escherichia coli Are Live Biotherapeutics for UTI
por: Rudick, Charles N., et al.
Publicado: (2014)

Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort
por: Weissberg, Dana, et al.
Publicado: (2018)

Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study
por: Namugenyi, Juliet, et al.
Publicado: (2021)

Challenges in achieving a target international normalized ratio for deep vein thrombosis among HIV-infected patients with tuberculosis: a case series
por: Sekaggya, C, et al.
Publicado: (2016)

Cost Effectiveness of a Pharmacy-Only Refill Program in a Large Urban HIV/AIDS Clinic in Uganda
por: Babigumira, Joseph B., et al.
Publicado: (2011)

Adherence monitoring methods to measure virological failure in people living with HIV on long-term antiretroviral therapy in Uganda
por: Okoboi, Stephen, et al.
Publicado: (2022)

Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda
por: Okoboi, Stephen, et al.
Publicado: (2018)

Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda
por: Omali, Denis, et al.
Publicado: (2023)

Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis
por: Manabe, Yukari C., et al.
Publicado: (2012)

Giardia duodenalis in Ugandan Children Aged 9–36 Months in Kampala, Uganda: Prevalence and Associated Factors
por: Ndeezi, Grace, et al.
Publicado: (2023)

Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2015)

Bladder Exposure to Gardnerella Activates Host Pathways Necessary for Escherichia coli Recurrent UTI
por: O’Brien, Valerie P., et al.
Publicado: (2021)

Seroepidemiology of maternally-derived antibody against Group B Streptococcus (GBS) in Mulago/Kawempe Hospitals Uganda - PROGRESS GBS
por: Kyohere, Mary, et al.
Publicado: (2020)

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
por: Sempa, Joseph, et al.
Publicado: (2012)

A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
por: Kiragga, Agnes N., et al.
Publicado: (2019)

Prevalence and incidence of hypertension in a heavily treatment-experienced cohort of people living with HIV in Uganda
por: Byonanebye, Dathan M., et al.
Publicado: (2023)

Genetically diverse uropathogenic Escherichia coli adopt a common transcriptional program in patients with UTIs
por: Sintsova, Anna, et al.
Publicado: (2019)

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Detection & characterization of necrotoxin producing Escherichia coli (NTEC) from patients with urinary tract infection (UTI)
por: Rahman, Helina, et al.
Publicado: (2014)

Phylogenetic Analysis and Antimicrobial Resistance Profiles of Escherichia coli Strains Isolated from UTI-Suspected Patients
por: RANJBAR, Reza, et al.
Publicado: (2020)

Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis
por: von Braun, Amrei, et al.
Publicado: (2017)

Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2020)

Prospective evaluation of radiographic manifestations of tuberculosis in relationship with CD4 count in patients with HIV/AIDS
por: Frey, Vanessa, et al.
Publicado: (2023)

First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2016)

Subtyping β-lactamase-producing Escherichia coli strains isolated from patients with UTI by MLVA and PFGE methods
por: Dolatyar Dehkharghani, Alireza, et al.
Publicado: (2021)

Approach for tuberculosis-associated immune reconstitution inflammatory syndrome in an HIV-negative patient
por: Weber, Michèle Rebecca, et al.
Publicado: (2021)

Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2020)

Antibacterial and Biofilm Inhibitory Activity of Medicinal Plant Essential Oils Against Escherichia coli Isolated from UTI Patients
por: Lagha, Rihab, et al.
Publicado: (2019)

UTI myths and misconceptions
Publicado: (2020)

“You would not be in a hurry to go back home”: patients’ willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda
por: Sebatta, Deborah Ekusai, et al.
Publicado: (2020)

Peer distribution of HIV self-test kits to men who have sex with men to identify undiagnosed HIV infection in Uganda: A pilot study
por: Okoboi, Stephen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sm2f5lbb18orr7ncspjneju4s0